Clinical Trials on Genetic Diseases

Total 379398 results

Johns Hopkins University
National Human Genome Research Institute (NHGRI)

Enrolling by invitation

Clinical Trial of the Sequence of Cardiovascular Genetic Counseling and Testing (RESEQUENCEGC)

Genetic Counseling | Inherited Cardiac Disease

United States
Dorothy Bautista, MD
Canadian Blood Services

Enrolling by invitation

Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis

Ligneous Conjunctivitis, Left Eye

Canada
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Not yet recruiting

Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic
Fundación Academia Española de Dermatología

Recruiting

Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy (BIOBADATOP)

Dermatitis, Atopic

Spain
Merck Sharp & Dohme LLC

Active, not recruiting

Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)

Dermatitis, Atopic

United States, Belgium, Bulgaria, Canada, Romania, Spain
SCM Lifescience Co., LTD.

Completed

Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

Korea, Republic of
Kymab Limited

Completed

A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

Germany, Poland, Spain, United Kingdom
Pierre Fabre Dermo Cosmetique

Terminated

Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD

Dermatitis, Atopic

France
Regeneron Pharmaceuticals
Sanofi

Completed

Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL) (Liberty AD)

Dermatitis, Atopic

United States, Germany, Poland, United Kingdom
SCM Lifescience Co., LTD.

Enrolling by invitation

Long-Term Safety Follow-Up Study of SCM-AGH in Subjects Who Participated and Administered SCM-AGH in to Severe Atopic Dermatitis Clinical Trials

Dermatitis, Atopic

Korea, Republic of
MYOR Ltd.
Assuta Ashdod Hospital

Withdrawn

Moisturizer to Prevent Atopic Dermatitis (ACE-AD)

Dermatitis, Atopic
Regeneron Pharmaceuticals
Sanofi

Completed

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

Dermatitis, Atopic

United States, Germany, Poland, Canada, Czechia, United Kingdom
Boston Children's Hospital
Pfizer

Completed

Improving Therapeutic Patient Education for Atopic Dermatitis: Evaluation of a Parent Handbook

Dermatitis, Atopic

United States
LEO Pharma
Bayer

Completed

An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids (Ointment TS-AD)

Dermatitis, Atopic

Japan
Pfizer

Completed

Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation

Dermatitis, Atopic

United States
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Completed

Sculptra Aesthetic for the Treatment of Upper Knee Skin Laxity

Knee | Lax Skin

United States
Philips Electronics Nederland BV
University Hospital, Geneva; Philipps University Marburg Medical Center; University...

Completed

Treatment of Atopic Dermatitis by a Full-Body Blue Light Device (AD-Blue)

Dermatitis, Atopic

Germany, Switzerland
Ajou University School of Medicine

Completed

Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis

Dermatitis, Atopic

Korea, Republic of
Regeneron Pharmaceuticals
Sanofi

Completed

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis (SOLO 1)

Dermatitis, Atopic

United States, Germany, Spain, Bulgaria, Japan, Canada, Denmark, Finland, Singapore, Estonia
GlaxoSmithKline

Completed

A Study Assessing GW870086's Potential to Cause Skin Thinning

Dermatitis, Atopic

Germany
Biopolis S.L.
Korott, S.L.

Completed

Intervention Study to Evaluate a Probiotic in Mild Atopic Dermatitis Young Patients

Dermatitis, Atopic

Spain
Astellas Pharma Inc

Completed

Distribution of Tacrolimus in Skin, Atopic Dermatitis

Dermatitis, Atopic

Ireland
Astellas Pharma Inc

Completed

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

Dermatitis, Atopic

France, United Kingdom, Spain, Belgium, Portugal, Netherlands, Finland, Czech Republic, Germany, Hungary, Italy
Astellas Pharma Inc

Completed

Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis

Dermatitis, Atopic

United Kingdom, Finland, Ireland, Canada, Latvia
Boehringer Ingelheim

Completed

WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients

Dermatitis, Atopic
Janssen-Cilag Ltd.,Thailand

Completed

An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis

Dermatitis, Atopic

Vietnam
Galderma Brasil Ltda.

Completed

Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application

Dermatitis, Atopic

Brazil
National Cancer Institute (NCI)

Completed

Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China

Lung Neoplasms

China
National Cancer Institute (NCI)

Completed

Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)

Dyskeratosis Congenita | Telomere Biology Disorders

United States
Spark Therapeutics

Completed

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

Hematologic Diseases | Hemophilia A | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Blood Coagulation Disorder | Factor VIII Deficiency

United States, Australia, Thailand, Canada
Almirall, S.A.

Completed

A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine

Eczema | Dermatitis, Atopic

Austria, Belgium, France, Germany, Netherlands, Poland, Spain, United Kingdom
Sofwave Medical LTD

Completed

SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow

Skin Laxity

United States
McMaster University
AstraZeneca

Completed

Effect of Benralizumab in Atopic Dermatitis

Skin Diseases | Immune System Diseases | Hypersensitivity | Hypersensitivity, Immediate | Genetic Diseases, Inborn | Skin Diseases, Genetic | Dermatitis | Eczema | Skin Diseases, Eczematous | Dermatitis, Atopic

Canada
Sciton

Completed

Hybrid Fractional Laser for Treatment of Off Face Body Skin Quality

Skin Laxity

United States
Cytrellis Biosystems, Inc.

Unknown

Pivotal Study to Evaluate the Effectiveness of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles

Laxity; Skin

United States
Ulthera, Inc

Completed

Treatment of the Face and Neck With Lower Ulthera System Energy Settings

Skin Laxity

United States
Procter & Gamble Beauty

Completed

Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis

Eczema | Dermatitis, Atopic

United States
Apsara Medical Corporation

Completed

Application of the Apsara Thermal Wand System

Tightening of Skin Laxity

United States
Edimer Pharmaceuticals

Completed

Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia (ECP-015)

X-Linked Hypohidrotic Ectodermal Dysplasia

United States, United Kingdom, France, Germany, Italy
Edimer Pharmaceuticals

Completed

X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey (X-CORS)

Hypohidrotic Ectodermal Dysplasia | X-Linked Hypohidrotic Ectodermal Dysplasia

United States
Edimer Pharmaceuticals
National Foundation of Ectodermal Dysplasia

Completed

Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype (ECP-006)

Hypohidrotic Ectodermal Dysplasia | X-Linked Hypohidrotic Ectodermal Dysplasia

United States
University of Guelph
McMaster University; Laval University

Not yet recruiting

Phe for Me? The Effects of L-Phe on PKU Carriers and Non-carriers (Phe for Me)

Autosomal Recessive Disorder (Genetic Carriers of PKU)

Canada
West Kazakhstan Medical University

Recruiting

Clinical and Genetic Markers of Bone Metabolism in Children Under One Year

Child Development | Genetic Change | Bone Remodeling Disorder

Kazakhstan
Hamilton Health Sciences Corporation
Southlake Regional Health Centre; Federal Economic Development Agency for Southern... and other collaborators

Completed

The DNA-Based Lifestyle Enhancement Trial (DNAble)

Health Behavior | Cardiovascular Risk Factor | Genetic Information

Canada
Hillel Yaffe Medical Center
Wingate Institute

Unknown

Genetic Polymorphism and Israeli Top-level Swimmers' Performance and Expertise

Genetic Polymorphism Connected to Top-level Swimmers

Israel
Mayo Clinic

Completed

Role Of Phosphorus And FGF 23 In Patients With Dent Disease

Dent Disease

United States
Atlas Biomed

Completed

Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Genetic Predisposition | Metagenome

Russian Federation
Nantes University Hospital

Completed

Neurological Fate, Prematurity and Genetic Susceptibility Factors (GENIMOC)

Polymorphism, Restriction Fragment Length | Premature | Infertility of Cervical Origin

France
Lev-Hasharon Mental Healtlh Center

Unknown

Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy (BAD)

Bipolar Affective Disorder

Israel
AB2 Bio Ltd.

Completed

Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency

NLRC4-MAS | XIAP Deficiency

United States, Canada, Germany

Clinical Trials on Genetic Diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations